Akira Fukutomi
Shizuoka Cancer Center(JP)
Publications by Year
Research Areas
Pancreatic and Hepatic Oncology Research, Colorectal Cancer Treatments and Studies, Gastric Cancer Management and Outcomes, Cholangiocarcinoma and Gallbladder Cancer Studies, Neuroendocrine Tumor Research Advances
Most-Cited Works
- → Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01)(2016)1,108 cited
- → Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan(2010)740 cited
- → Randomized Phase III Study of Gemcitabine Plus S-1, S-1 Alone, or Gemcitabine Alone in Patients With Locally Advanced and Metastatic Pancreatic Cancer in Japan and Taiwan: GEST Study(2013)629 cited
- → Randomized clinical trial of adjuvant gemcitabine chemotherapy versus observation in resected bile duct cancer(2018)385 cited
- → Combination gemcitabine plus S-1 versus gemcitabine plus cisplatin for advanced/recurrent biliary tract cancer: the FUGA-BT (JCOG1113) randomized phase III clinical trial(2019)328 cited
- → Phase II study of FOLFIRINOX for chemotherapy‐naïve Japanese patients with metastatic pancreatic cancer(2014)173 cited
- → Weekly paclitaxel as second-line chemotherapy for advanced or recurrent gastric cancer(2006)146 cited
- → Randomized Phase III Trial of Adjuvant Chemotherapy with Gemcitabine versus S-1 in Patients with Resected Pancreatic Cancer: Japan Adjuvant Study Group of Pancreatic Cancer (JASPAC-01)(2008)102 cited
- → Phase I study of TAS-102 treatment in Japanese patients with advanced solid tumours(2012)96 cited
- → Randomized phase II/III clinical trial of elpamotide for patients with advanced pancreatic cancer: PEGASUS‐PC Study(2015)91 cited